
Snvia
Innovative medical products leveraging embeddable microneedle and therapeutic polymer technology for drug delivery and diagnosis.
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
Total Funding | 000k |
Related Content
SNVIA, a subsidiary of Pusan National University PNU technology holdings company, specializes in the development and manufacturing of advanced medical products. The company focuses on embeddable microneedle and therapeutic polymer technology, which are used for transdermal drug delivery and diagnostic applications. SNVIA serves a diverse range of clients in the healthcare sector, including hospitals, research institutions, and pharmaceutical companies. Operating in the medical technology market, SNVIA's business model revolves around the production and sale of specialized medical products such as the LUMIDLE Beauty Patch and HAMA hydrogels. These products are designed to improve drug delivery efficiency and tissue engineering outcomes. Revenue is generated through direct sales and international shipping, with competitive pricing strategies to attract a global clientele.
Keywords: embeddable microneedle, therapeutic polymer, drug delivery, diagnosis, medical technology, healthcare, LUMIDLE Beauty Patch, HAMA hydrogels, tissue engineering, global clientele.